Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Evolent Health Inc’s stock clocked out at $10.08, up 0.10% from its previous closing price of $10.07. In other words, the price has increased by $0.10 from its previous closing price. On the day, 3.66 million shares were traded. EVH stock price reached its highest trading level at $10.205 during the session, while it also had its lowest trading level at $9.57.
Ratios:
To gain a deeper understanding of EVH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 0.85. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On December 03, 2024, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $36 to $29.
Stephens Downgraded its Overweight to Equal-Weight on November 08, 2024, whereas the target price for the stock was revised from $38 to $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Holder Diane bought 2,735 shares for $9.33 per share. The transaction valued at 25,518 led to the insider holds 70,584 shares of the business.
McCarthy Daniel Joseph bought 11,040 shares of EVH for $99,470 on Mar 06 ’25. The PRESIDENT now owns 389,004 shares after completing the transaction at $9.01 per share. On Mar 07 ’25, another insider, Jelinek Richard M, who serves as the Director of the company, bought 30,000 shares for $9.12 each. As a result, the insider paid 273,750 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 1175237248 and an Enterprise Value of 1959382912. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.46 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 0.767 whereas that against EBITDA is 20.844.
Stock Price History:
The Beta on a monthly basis for EVH is 1.05, which has changed by -0.6679842 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, EVH has reached a high of $33.63, while it has fallen to a 52-week low of $8.35. The 50-Day Moving Average of the stock is 2.95%, while the 200-Day Moving Average is calculated to be -44.02%.
Shares Statistics:
It appears that EVH traded 2.50M shares on average per day over the past three months and 1961820 shares per day over the past ten days. A total of 115.04M shares are outstanding, with a floating share count of 113.57M. Insiders hold about 2.59% of the company’s shares, while institutions hold 107.12% stake in the company. Shares short for EVH as of 1741910400 were 13903446 with a Short Ratio of 5.56, compared to 1739491200 on 12333712. Therefore, it implies a Short% of Shares Outstanding of 13903446 and a Short% of Float of 13.569999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
